Gomekli

Active Ingredient(s): Mirdametinib
FDA Approved: * February 11, 2025
Pharm Company: * SPRINGWORKS THERAPEUTICS INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Gomekli 1 mg Oral Capsule
NDC: 82448-130
Labeler:
Springworks Therapeutics, Inc.
Gomekli 1 mg Oral Tablet, for Suspension
NDC: 82448-134
Labeler:
Springworks Therapeutics, Inc.
Gomekli 2 mg Oral Capsule
NDC: 82448-260
Labeler:
Springworks Therapeutics, Inc.